MedPath
TGA Approval

APO-RISEDRONATE risedronate sodium 150 mg tablets blister pack (181970)

181970

APO-RISEDRONATE risedronate sodium 150 mg tablets blister pack

Arrotex Pharmaceuticals Pty Ltd

March 8, 2012

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/159898801d26acbd8311d244d3c61296.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/7dd88a82ca5a93e36a863e04574d229e.pdf

Active Ingredients

risedronate sodium hemipentahydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-RISEDRONATE risedronate sodium 150 mg tablets blister pack (181970) - TGA 批准文号 | MedPath